Claim OwnershipA Chat with Anat
Subscribed: 3Played: 5
Subscribe
© 2025 A Chat with Anat
Description
"A Chat with Anat" is a series for ophthalmologists who are interested in improving delivery of care for patients living with retinal disease, and for those interested in clinically-challenging situations or controversies in care. I’m Professor Anat Loewenstein, Chair of the Department of Ophthalmology at Tel Aviv Sourasky Medical Centre in Israel, and Professor of Ophthalmology and Vice Dean at Tel Aviv University. For each episode, I will be joined by internationally renowned colleagues to discuss these important topics. This podcast series is sponsored and organized by Bayer and produced by ApotheCom.
This podcast series is produced and funded by Bayer. The views and opinions expressed throughout this podcast are the speakers' own, based on their clinical experience and expertise. This is not intended for UK audiences.
20 Episodes
Reverse
In this special episode, I am joined by two of my long-time friends and collaborators, Professor Jean-François Korobelnik, my Co-chair of the Vision Academy and Professor of Ophthalmology at the University Hospital of Bordeaux, France, and Dr Jane Barratt, my Co-chair of the Barometer Program, and former Secretary General and Global Advisor at the International Federation of Ageing. Tune in as we unpack the statement “From the Community, For the Community,” exploring how collaborations betwee...
In this special episode, the roles have been reversed! Your host is Professor Tariq Aslam, Professor of Ophthalmology and Interface Technologies at the University of Manchester in the United Kingdom, who asked me questions sent in by my retinal community colleagues. Tune in to hear how I balance my busy career with my well-being, the pep talks I give to nervous first-time patients and trainees, myths about retinal disease I’d like to erase forever, and even an embarrassing moment in my career...
My guest for this special episode is Professor Paolo Lanzetta, Chair of the Department of Ophthalmology at the University of Udine, Italy. In this episode, Paolo and I explore the importance of monitoring the fellow eye of patients with nAMD. We also discuss methods and techniques for early detection of disease, the difference in monitoring for patients with DME, and the Vision Academy’s evidence-based guidance on monitoring the fellow eye. To learn more about monitoring the fellow eye ...
My guest for this special episode is Prof. Jean- François Korobelnik from the Department of Ophthalmology at the University Hospital, and at CHU Bordeaux, in Bordeaux, France. In this episode, Jean-François and I explore the importance of choosing the right regimen for our patients with nAMD. We discuss the evidence we can gather from clinical trials, and the lessons we learn from patients we see during clinical practice. We also explore the algorithm developed by the Vision Academy to choose...
My guest for this special episode is Dr. John Kitchens, Vitreoretinal Surgeon with Retina Associates of Kentucky in the USA. In this episode, John and I explore the importance of holistic patient care. We also highlight the latest advances in home monitoring technologies in retinal disease, and how artificial intelligence (AI) can be used to aid in disease monitoring and optimization of clinic organization. To learn more about the current status of AI in screening, diagnosing and managi...
My guest for this episode is Professor David Wong from the Department of Ophthalmology and Vision Sciences, University of Toronto and Unity Health Toronto in Toronto, Canada. In this episode, David and I discuss the Vision Academy’s algorithms for suspending treatment for nAMD in the context of treatment futility and success. Our conversation highlights the monitoring considerations and criteria used to define treatment futility and success, and the potential of predictive biomarkers an...
My guest for this special episode is Peter Holland, Chief Executive of the International Agency for the Prevention of Blindness (IAPB). We speak about the importance of World Sight Day, and discuss how different initiatives, such as the Love Your Eyes campaign, have helped put eye health on the global agenda in collaboration with members and partners. We also highlight how clinicians can leverage their voices and influence to share knowledge, shape policies, and strengthen cross-sector collab...
My guests for this episode are Professor Sobha Sivaprasad, Consultant Ophthalmologist at Moorfields Eye Hospital and Professor of Retinal Clinical Studies at the UCL Institute of Ophthalmology in London, and Professor Gemmy Cheung, Professor and Senior Consultant Ophthalmologist at the Singapore National Eye Centre, Duke-NUS Medical School, National University of Singapore. In this special episode, we discuss our experiences as women working in ophthalmology, and the advice we would give to y...
In this episode, my guests Vision Academy and Barometer Program member Professor Jean-François Korobelnik, Professor and Head of the Ophthalmology Department at the University Hospital of Bordeaux in France, and Vision Academy member Professor Robyn Guymer, Deputy Director at the Centre for Eye Research and Professor of Ophthalmic at the University of Melbourne in Australia, discuss considerations for devising flexible and individualized treatment regimens for patients with nAMD with residual...
In this episode, Vision Academy members Professor Annabelle Okada, Professor of Ophthalmology and Director of the Ocular Inflammation Service and the Macular Disease Service at the Kyorin University School of Medicine in Japan, and Professor Ian Pearce, Consultant Ophthalmologist and Vitreoretinal Surgeon at the Royal Liverpool University Hospital in the UK, discuss the pachychoroid spectrum. Using practical examples from their own clinics, they explore how accurate diagnosis, monitoring, pro...
My guest for this special episode recorded live at the 15th Annual Congress on Controversies in Ophthalmology (COPHy) is Professor Tariq Aslam, Professor of Ophthalmology and Interface Technologies at University of Manchester, United Kingdom. In this episode, Tariq and I discuss whether the introduction of next generation therapies for the clinical management of retinal diseases will open the door to a new era for patients and clinicians. We also consider how learnings from the Barome...
My guest for this episode is Professor Nicole Eter, Professor of Ophthalmology and Chair of the Department of Ophthalmology at the University of Münster, Germany. In this episode, Nicole and I chat about the different macular neovascularization (MNV) subtypes, discussing the diagnostic tools used to classify MNV subtypes, their defining characteristics and variants, and the impact of these on our patients. Our conversation highlights why it’s important to tailor treatment to MNV subtype for...
In this episode, Professor Paul Mitchell, Professor of Ophthalmology at the University of Sydney in Australia, and Dr Andrew Chang, Principal Retinal Specialist at the Sydney Retina Clinic and Day Surgery in Australia, share their thoughts on the optimal anti-VEGF therapy regimens to treat retinal vascular diseases, including nAMD and DME. They discuss how the best regimen should be effective in maintaining vision, proactive, individualized to the patient’s needs, and convenient for the patie...
We are delighted to announce that we are expanding A Chat with Anat! We will be partnering with the Vision Academy, a group of retinal experts who collaborate to provide guidance to the retinal community. I will be joined by internationally renowned Vision Academy experts to discuss practice-focused topics covering clinical challenges in ophthalmology and controversies in care. In this episode of A Chat with Anat, Professor Paul Mitchell, Professor of Ophthalmology at the University of ...
My guest for this episode is Professor Tariq Aslam, Professor of Ophthalmology and Interface Technologies at the University of Manchester and a Consultant Ophthalmologist specializing in the management of retinal disease. In this episode, we speak about how important it is to consider anxiety and depression when managing our patients with nAMD, and hear about the quick and effective measures that listeners can implement in their own clinic to identify patients at risk of anxiety and depressio...
My guest for this episode is Professor Richard Gale, Professor of Ophthalmology at Hull York Medical School, University of York, UK, and Honorary Consultant Medical Ophthalmologist at the National Health Service’s York Teaching Hospital. In this episode, Richard and I will chat about how patients’ emotions, experiences, and perceptions related to anti-vascular endothelial growth factor (anti-VEGF) treatment can influence their treatment adherence and persistence. Despite this, the patient’s...
My guest for this episode is Professor Paul Mitchell, Emeritus Professor of Ophthalmology at the University of Sydney, Consultant Ophthalmologist at the Western Sydney Local Health District, and Principal of Sydney West Retina Pty Ltd in Australia. As treatment for neovascular age-related macular degeneration (nAMD) has evolved through the 21st century, so have the expectations of our patients. Paul joins me to chat about how developments in treatment modalities and regimens led to the evol...
My guest is Dr. Jane Barratt, Secretary General of the International Federation on Ageing. In this episode, Jane and I discuss ways in which we can improve our communication with our patients to enable realistic expectation-setting. We also speak about how we can meaningfully engage with, and empower, our patients to support them in managing their nAMD. This is not intended for UK audiences. Speaker disclosures: Professor Anat Loewenstein Consultancy, Research grants: Allergan, Bayer, Beyeo...
Today my guest is Mr James Talks, Consultant Ophthalmologist at the Newcastle Eye Centre in Newcastle, UK. He joins me to discuss how clinic organization can impact adherence and persistence and what aspects we can modify to ensure a better patient experience and optimize adherence to treatment. This is not intended for UK audiences. Speaker disclosures: Professor Anat Loewenstein Consultancy, Research grants: Allergan, Bayer, Beyeonics Surgical, KHB, Novartis, Notal Vision, Oculis, Oxurio...
My first guest is Professor Richard Gale, Consultant Medical Ophthalmologist, and the Clinical Director at the York Teaching Hospital NHS Foundation Trust, UK. In this episode, we discuss the latest publications and strategies that are employed to support patients in continuing to attend appointments and receive treatment. I have included below the links to the publications that we discuss during this podcast. Okada M, et al. Ophthalmology. 2021;128(2):234-47 Okada M, et al. JAMA Ophthal...
Comments
Download from Google Play
Download from App Store
United States